11 Osteogenesis Imperfecta Clinical Trials in The Bronx, NY (2026)

Q: How do I join a clinical trial in The Bronx?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you.

Recruiting Osteogenesis Imperfecta Studies in The Bronx

NCT07412002Recruiting

Quality of End-of-Life Care for Children With Cancer

This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this...

The Bronx, NY2,425 participantsChildren's Oncology Group

View Study Details

NCT06796062Recruiting

Psilocybin for Opioid Use Disorder (OUD)

This is a double-blind, adaptive, 2-stage, multi-site, phase 2 randomized controlled clinical trial designed to evaluate effects of moderate and high dose psilocybin, relative to low-dose psilocybin c...

The Bronx, NY480 participantsNYU Langone Health

View Study Details

NCT06569667Recruiting

Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven...

The Bronx, NY292 participantsFriends Research Institute, Inc.

View Study Details

NCT05304377Recruiting

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in patients with chronic myeloid leukemia with and with...

The Bronx, NY250 participantsEnliven Therapeutics

View Study Details

NCT05039554Recruiting

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

The proposed IMPOWR Research Center at Montefiore-Einstein (IMPOWR-ME) will create a multidisciplinary and synergistic program of research to test multimodal treatments that address both chronic pain ...

The Bronx, NY127 participantsAlbert Einstein College of Medicine

View Study Details

NCT05342584Recruiting

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS

This is a Phase 1b, open-label study evaluating Venetoclax in combination with intensive induction and consolidation chemotherapy in previously untreated, adult patients with acute myeloid leukemia. I...

The Bronx, NY99 participantsMontefiore Medical Center

View Study Details

NCT05001750Recruiting

Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?

The principal objective of this study is to compare the incidence of ventriculostomy related infections (VRIs) in patients who receive twenty-four hours of antibiotics, beginning no more than sixty mi...

The Bronx, NY84 participantsMontefiore Medical Center

View Study Details

NCT05450718Recruiting

Low-dose Buprenorphine Initiation for Opioid Use Disorder

The purpose of this study is to test whether low-dose buprenorphine initiation for treatment of opioid use disorder is safe and effective....

The Bronx, NY70 participantsMontefiore Medical Center

View Study Details

NCT07510373Recruiting

Opioid Tapering After Hospital Discharge: Testing an Intervention to Improve Post-operative Opioid Prescribing

The investigator team proposes a randomized clinical trial (RCT) to test a discharge opioid taper support ("DOTS") intervention that is embedded in the providers' workflow in the EHR to prompt them to...

The Bronx, NY42 participantsMontefiore Medical Center

View Study Details

NCT07283094Recruiting

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

This is a Phase 1, uncontrolled, single-arm, open-label, nonrandomized, dose escalation, study of Decitabine (DAC)+Venetoclax (VEN)+FHD-286 in participants with newly diagnosed Acute Myeloid Leukemia ...

The Bronx, NY33 participantsMontefiore Medical Center

View Study Details

NCT04722263Recruiting

Radiotherapy for Keloids

The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids....

The Bronx, NY15 participantsMontefiore Medical Center

View Study Details

About Osteogenesis Imperfecta Clinical Trials in The Bronx

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 11 osteogenesis imperfecta clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 3,917 participants. Research is being sponsored by Children's Oncology Group, NYU Langone Health, Friends Research Institute, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in The Bronx — FAQ

Are there osteogenesis imperfecta clinical trials in The Bronx?

Yes, there are 11 osteogenesis imperfecta clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 11 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 13, 2026 from ClinicalTrials.gov